Lexeo Therapeutics, Inc.

LXEO · XNAS

CIK 1907108fmd_18ECD76B9SVCAX1P71QRD39S7DManufacturing · Biological Products, (No Diagnostic Substances)Template: Standard

Coverage: Jan 01, 2022 to Jun 30, 2026, 18 periods

AI-written

A model wrote this from the company's own SEC filings and our standardized facts. It is not reported fact, not an analyst's estimate, not a rating and not investment advice. Every claim shows what it rests on.